Refine
Has Fulltext
- yes (25)
Is part of the Bibliography
- yes (25)
Year of publication
Document Type
- Journal article (24)
- Conference Proceeding (1)
Keywords
- absolute configuration (3)
- chemistry (3)
- circular dichroism (3)
- molecular docking (3)
- Chemie (2)
- Holothuria spinifera (2)
- LC-HRESIMS (2)
- Streptomyces axinellae (2)
- anti-trypanosomal (2)
- cerebrosides (2)
- cytotoxic activity (2)
- cytotoxicity (2)
- marine natural product (2)
- marine sponge (2)
- naphthylisoquinoline alkaloids (2)
- protease inhibition (2)
- streptomyces (2)
- structure elucidation (2)
- tetromycin (2)
- (± )-dioncophyllacine A (1)
- ADME analysis (1)
- Alzheimer′s disease (1)
- Ancistrocladus ealaensis (1)
- Ancistrocladus likoko (1)
- Baltic Sea (1)
- Biologie (1)
- C-13 NMR (1)
- Dictyota (1)
- Dictyotaceae (1)
- Dioncophyllaceae (1)
- Dioncophyllaceae leaves (1)
- Eriodictyon californicum (1)
- Garcinia biflavonoids (1)
- H2A histone family member X (H2AX) (1)
- HRMS (1)
- Naphthylisoindolinone alkaloids (1)
- Phaeophyceae (1)
- RNA splicing (1)
- RNA-dependent RNA polymerase (1)
- SARS-CoV-2 (1)
- Scleractinia (1)
- Screening (1)
- Solution-state NMR (1)
- Stereochemistry (1)
- Structure elucidation (1)
- Stylissa carteri (1)
- Thalassodendron ciliatum (1)
- Triphyophyllum peltaturn (1)
- abietane (1)
- activating transcription factor 4 (ATF4) (1)
- alkaloids (1)
- ancistrocladinium A (1)
- anti-cancer-agent (1)
- antibacterial activity (1)
- ataxia teleagiectasia mutated (ATM) (1)
- azaphilone (1)
- bartalinia robillardoides (1)
- biflavanoids (1)
- bioactive compound (1)
- bioactivities (1)
- biosynthesis (1)
- brown seaweeds (1)
- cellular stress response (1)
- ceramide (1)
- cerebroside (1)
- ceriops decandra (1)
- chiral resolution (1)
- cysteine protease (1)
- decandrinin (1)
- dimers (1)
- discovery (1)
- docking (1)
- docking studies (1)
- drugs (1)
- ergosterol derivative (1)
- extractives (1)
- flavenoids (1)
- flavonoids (1)
- guttiferae (1)
- halichondria panicea (1)
- high-temperature NMR (1)
- laser (1)
- livingstonei (1)
- marine bacteria (1)
- marine fungi (1)
- marine macroalgae (1)
- marine natural products (1)
- metabolic analysis (1)
- methyltransferase (1)
- minimal inhibitory concentration (1)
- multiflora (1)
- multiple myeloma (1)
- naphthylisoquinoline alkaloid (1)
- natural products (1)
- obstructive pulmonary disease (1)
- optics (1)
- pancreatic cancer (1)
- pentaketide (1)
- phenazine (1)
- phosphodiesterase-4 inhibitor (1)
- proteasome inhibitor resistance (1)
- proteasome subunit beta type-5 (PSMB5) (1)
- quantum optics (1)
- rhizophoraceae (1)
- rofumilast (1)
- seagrass (1)
- spectroscopic analysis (1)
- stereochemistry (1)
- sterubin (1)
- tethya aurantium (1)
- zooxanthellae (1)
Institute
- Institut für Organische Chemie (20)
- Institut für Anorganische Chemie (4)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Julius-von-Sachs-Institut für Biowissenschaften (2)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Physikalische und Theoretische Chemie (1)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (1)
- Rudolf-Virchow-Zentrum (1)
Alzheimer′s disease (AD) is a neurological disorder with still no preventive or curative treatment. Flavonoids are phytochemicals with potential therapeutic value. Previous studies described the flavanone sterubin isolated from the Californian plant Eriodictyon californicum as a potent neuroprotectant in several in vitro assays. Herein, the resolution of synthetic racemic sterubin (1) into its two enantiomers, (R)‐1 and (S)‐1, is described, which has been performed on a chiral chromatographic phase, and their stereochemical assignment online by HPLC‐ECD coupling. (R)‐1 and (S)‐1 showed comparable neuroprotection in vitro with no significant differences. While the pure stereoisomers were configurationally stable in methanol, fast racemization was observed in the presence of culture medium. We also established the occurrence of extracted sterubin as its pure (S)‐enantiomer. Moreover, the activity of sterubin (1) was investigated for the first time in vivo, in an AD mouse model. Sterubin (1) showed a significant positive impact on short‐ and long‐term memory at low dosages.
A series of seven unusual dimeric naphthylisoquinoline alkaloids was isolated from the leaves of the tropical liana Ancistrocladus ealaensis J. Léonard, named cyclombandakamine A (1), 1-epi-cyclombandakamine A (2), and cyclombandakamines A3–7 (3–7). These alkaloids have a chemically thrilling structural array consisting of a twisted dihydrofuran-cyclohexenone-isochromene system. The 1′″-epimer of 4, cyclombandakamine A1 (8), had previously been discovered in an unidentified Ancistrocladus species related to A. ealaensis. Both lianas produce the potential parent precursor, mbandakamine A (9), but only A. ealaensis synthesizes the corresponding cyclized form, along with a broad series of slightly modified analogs. The challenging isolation required, besides multi-dimensional chromatography, the use of a pentafluorophenyl stationary phase. Featuring up to six stereocenters and two types of chiral axes, their structures were elucidated by means of 1D and 2D NMR, HRESIMS, in combination with oxidative chemical degradation experiments as well as chiroptical (electronic circular dichroism spectroscopy) and quantum chemical calculations. Compared to the ‘open-chain’ parent compound 9, these dimers displayed rather moderate antiplasmodial activities.
Three unusual heterodimeric naphthylisoquinoline alkaloids, named ealapasamines A-C (1–3), were isolated from the leaves of the tropical plant Ancistrocladus ealaensis J. Léonard. These ‘mixed’, constitutionally unsymmetric dimers are the first stereochemically fully assigned cross-coupling products of a 5,8′- and a 7,8′-coupled naphthylisoquinoline linked via C-6′ in both naphthalene portions. So far, only two other West and Central Ancistrocladus species were known to produce dimers with a central 6,6″-axis, yet, in contrast to the ealapasamines, usually consisting of two 5,8′-coupled monomers, like e.g., in michellamine B. The new dimers 1–3 contain six elements of chirality, four stereogenic centers and the two outer axes, while the central biaryl axis is configurationally unstable. The elucidation of the complete stereostructures of the ealapasamines was achieved by the interplay of spectroscopic methods including HRESIMS, 1D and 2D NMR (in particular ROESY measurements), in combination with chemical (oxidative degradation) and chiroptical (electronic circular dichroism) investigations. The ealapasamines A-C display high antiplasmodial activities with excellent half-maximum inhibition concentration values in the low nanomolar range.
Bioactivity-guided fractionation of a methanolic extract of the Red Sea cucumber Holothuria spinifera and LC-HRESIMS-assisted dereplication resulted in the isolation of four compounds, three new cerebrosides, spiniferosides A (1), B (2), and C (3), and cholesterol sulfate (4). The chemical structures of the isolated compounds were established on the basis of their 1D NMR and HRMS spectral data. Metabolic profiling of the H. spinifera extract indicated the presence of diverse secondary metabolites, mostly hydroxy fatty acids, diterpenes, triterpenes, and cerebrosides. The isolated compounds were tested for their in vitro cytotoxicities against the breast adenocarcinoma MCF-7 cell line. Compounds 1, 2, 3, and 4 displayed promising cytotoxic activities against MCF-7 cells, with IC\(_{50}\) values of 13.83, 8.13, 8.27, and 35.56 µM, respectively, compared to that of the standard drug doxorubicin (IC\(_{50}\) 8.64 µM). Additionally, docking studies were performed for compounds 1, 2, 3, and 4 to elucidate their binding interactions with the active site of the SET protein, an inhibitor of protein phosphatase 2A (PP2A), which could explain their cytotoxic activity. This study highlights the important role of these metabolites in the defense mechanism of the sea cucumber against fouling organisms and the potential uses of these active molecules in the design of new anticancer agents.
The N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A belongs to a novel class of natural products with potent antiprotozoal activity. Its effects on tumor cells, however, have not yet been explored. We demonstrate the antitumor activity of ancistrocladinium A in multiple myeloma (MM), a yet incurable blood cancer that represents a model disease for adaptation to proteotoxic stress. Viability assays showed a potent apoptosis-inducing effect of ancistrocladinium A in MM cell lines, including those with proteasome inhibitor (PI) resistance, and in primary MM cells, but not in non-malignant blood cells. Concomitant treatment with the PI carfilzomib or the histone deacetylase inhibitor panobinostat strongly enhanced the ancistrocladinium A-induced apoptosis. Mass spectrometry with biotinylated ancistrocladinium A revealed significant enrichment of RNA-splicing-associated proteins. Affected RNA-splicing-associated pathways included genes involved in proteotoxic stress response, such as PSMB5-associated genes and the heat shock proteins HSP90 and HSP70. Furthermore, we found strong induction of ATF4 and the ATM/H2AX pathway, both of which are critically involved in the integrated cellular response following proteotoxic and oxidative stress. Taken together, our data indicate that ancistrocladinium A targets cellular stress regulation in MM and improves the therapeutic response to PIs or overcomes PI resistance, and thus may represent a promising potential therapeutic agent.